Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 1,146 | 1,099 | 1,106 | 601 | 607 |
| Gross Profit | 1,146 | 1,099 | 1,106 | 620 | 600 |
| Operating Expenses | 1,911 | 1,853 | 2,237 | 2,860 | 2,780 |
| Operating Income | -765 | -754 | -1,131 | -2,259 | -2,173 |
| Other Income | 0 | 0 | 0 | -11 | 3 |
| Pre-tax Income | -765 | -754 | -1,131 | -2,270 | -2,170 |
| Net Income Continuous | -765 | -754 | -1,131 | -2,256 | -2,179 |
| Net Income | $-765 | $-754 | $-9,585 | $-2,256 | $-2,179 |
| EPS Basic Total Ops | -0.28 | -0.28 | -3.40 | -0.80 | -0.76 |
| EPS Basic Continuous Ops | -0.28 | -0.28 | -0.40 | -0.80 | -0.77 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.02 | N/A |
| EPS Diluted Total Ops | -0.28 | -0.28 | -3.40 | -0.80 | -0.76 |
| EPS Diluted Continuous Ops | -0.28 | -0.28 | -0.40 | -0.80 | -0.77 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.02 | N/A |
| EBITDA(a) | $-686 | $-638 | $-974 | $-1,939 | $-2,193 |